CompletedPhase 2NCT01162551

Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital of Philadelphia
Principal Investigator
Susan R. Rheingold, MD
Children's Hospital of Philadelphia
Intervention
Sirolimus and Methotrexate(drug)
Enrollment
5 target
Eligibility
25 years · All sexes
Timeline
20102017

Study locations (1)

Collaborators

The Leukemia and Lymphoma Society

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01162551 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials